Work

Debulking Conventional Chemotherapy before Treatment By Anti-BCMA Bispecific Antibody in Extramedullary and/or High Tumor Burden Relapsed/Refractory Multiple Myeloma

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-203778

Authors: Thomas Chalopin, Hélène Demarquette, Andrea Pieragostini, Cécile Sonntag, Caroline Jacquet, Zoe van De Wyngaert, Anne Rumpler, Murielle Roussel, Gaelle Labouré, Veronique Morel, Laure Vincent, Valéry Salle, Elise Cellerin, Titouan Cazaubiel, Salomon Manier

Institutions: Centre Hospitalier Universitaire de Tours, CHU Dijon Bourgogne, Hôpitaux Universitaires de Strasbourg, Hôpital d'Hautepierre, Centre Hospitalier Régional et Universitaire de Nancy, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Centre Hospitalier Universitaire de Besançon, Centre Hospitalier Universitaire de Limoges, Pitié-Salpêtrière Hospital, Centre Hospitalier Universitaire de Montpellier, Hôpital Saint Eloi, Centre Hospitalier Universitaire Amiens-Picardie, Centre Hospitalier Universitaire de Bordeaux, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405041832

Cites:

Cited by: 3

Related to: 10